Coupling Complementary Pathways in a Bacterial Co-culture Enables 4-Aminophenol Removal during Paracetamol Degradation
Pharmaceutical biodegradation can generate potentially toxic metabolites that persist after the parent compound has been removed, posing additional risks to aquatic environments. Microbial co-cultures offer a promising strategy to address this challenge by combining complementary metabolic capabilities to remove both pharmaceuticals and their harmful transformation products by coupling complementary degradation pathways. Here, we investigated a two-species co-culture combining the paracetamol-degrading bacterium Delftia P1 with Microbacterium lacus to enable subsequent 4-AP removal. While Delftia P1 efficiently degraded paracetamol, it accumulated 4-AP as a dead-end metabolite. M. lacus was selected to complement this metabolic limitation because its genome contains a homolog of sadB, a monooxygenase gene involved in 4-AP transformation. The relative abundance of the two strains strongly influenced 4-AP removal, with the highest efficiency achieved at a Delftia P1:M. lacus cell-density ratio of 1:100, corresponding to an OD600nm ratio of 1:10. At this ratio, the co-culture achieved complete removal of paracetamol and 4-AP within 6 and 24 h, respectively. Its capacity was tested in wastewater, where 100% of paracetamol were removed within 4 h and no accumulation of 4-AP was observed within 24 h. These findings demonstrate the potential of cocultivating bacteria with complementary metabolic capabilities to address both pharmaceutical contamination and transformation-product accumulation. Moreover, the highest 4-AP removal was achieved when M. lacus was present at a 100-fold higher cell density than Delftia P1, highlighting the importance of considering relative cell densities when designing co-cultures.
Authors
- Pilar Junier (ORCID: https://orcid.org/0000-0002-8618-3340)
- Philippe F.-X. Corvini (ORCID: https://orcid.org/0000-0002-2991-5031)
- Marcel Suleiman (ORCID: https://orcid.org/0000-0001-9141-8231)
- Cristina Zimmardi
- Francesca Demaria (ORCID: https://orcid.org/0009-0003-0497-0055)
- Matthias Schaffter
Institutions
- FHNW University of Applied Sciences and Arts Northwestern Switzerland (CH)
Publication Details
- Journal
- bioRxiv (Cold Spring Harbor Laboratory)
- Published
- 2026-11-13
- DOI
- https://doi.org/10.64898/2026.11.11.765863
- Primary Topic
- Pharmaceutical and Antibiotic Environmental Impacts
- Type
- preprint
Funders
- European Commission
- HORIZON EUROPE Framework Programme
- Staatssekretariat für Bildung, Forschung und Innovation